"JavaScript is a standard programming language that is included to provide interactive features, Kindly enable Javascript in your browser. For details visit help page"
भारत सरकार
Government of india
रसायन एवं उर्वरक मंत्रालय
Ministry of Chemicals and Fertilizers
Skip to main content
Search
The Web
PHARMACEUTICALS.GOV.IN
Search
A
+
A
A
-
A
A
Language
हिन्दी
औषध विभाग
Department of
Pharmaceuticals
Menu
Home
About Us
About the Department
Business Allocation
Agencies Under Department
Who's Who
Organisation Chart
Precedent Book
Procurement Projections
Citizen Charter
RTI
RTI - ACT
CPIO'S
Proactive Disclosure
RTI-Online Application/ Appeal
Work Allocation and Committees
Acts
Policies
Schemes
Finance & Budget
Chief Controller Of Accounts
Plan Schemes
Budget and Expenditure
Detailed Demand for Grants
Swachh Bharat
Constitution Day & Citizen Duties
About Constitution
Home
>>
What's New
Documents/ Reports
Tenders
Recruitment
Events
Media Gallery
Other Links
Review Orders
Annual Report
Important Links
Press Information Bureau
Hindi Shabdawali
STQC Certificate
What's New
All Documents
Title
Monthly Summary report for the Month of October-2021
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereofregarding.
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India
Report on Swacchata Pakhwada from 1-15 September, 2021
Monthly Summary report for the month of September-2021
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Monthly Summary report for the month of August-2021
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC).
Monthly Summary report for the month of July, 2021
Corrigendum under PLI scheme for Pharmaceuticals
Amendment in paragraph 18 of dpco, 2013
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract.
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices
Order on Amendment in the Drugs (Prices Control) Order, 2013 for inclusion on Form VI
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013.
Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS)
Pharmaceutical Promotion and Development Scheme (PPDS)
Assistance to Pharmaceutical Industry for Common Facilities
Monthly Summary report for the month of June, 2021
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg
Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
Review order of M/s Emcure Pharmaceuticals Limited, Order Date-25.06.2021
Monthly Summary report for the Month of May, 2021
Annual Report 2020-21
Observing the 7th International Yoga Day, 2021.
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices.
Production Linked Incentive (PLI) scheme for Pharmaceuticals
Monthly Summary report for the Month of April, 2021
Allocation of Tocilizumab Dated 11th May 2021
State-wise allocation of Remdesivir vials for period 21st April to 16th May, 2021
Revised allocation of Tocilizumab to States
State-wise allocation of Remdesivir vials for period 21st April to 9th May, 2021
Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country.
Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices.
Monthly Summary report for the Month of March, 2021
Monthly Summary report for the Month of February,2021
Pages
1
2
next ›
last »
औषध विभाग
Department of
